Is Palantir Stock a Millionaire Maker?
Palantir (NASDAQ:PLTR) has shot upward over the last year and…
Sell
36
ELV Quote, Financials, Valuation and Earnings
Last price:
$408.50
Seasonality move
:
4.13%
Day range:
$408.11 - $419.38
52-week range:
$362.21 - $567.26
Dividend yield:
1.62%
P/E ratio:
15.93x
P/S ratio:
0.52x
P/B ratio:
2.17x
Volume:
1.3M
Avg. volume:
1.8M
1-year change:
-22.2%
Market cap:
$92.3B
Revenue:
$176.8B
EPS (TTM):
$25.63
ELV Analysts' Consensus Rating
The 17 analysts providing 12-month price projections for Elevance Health shares anticipate an average target of $505.55, ranging from a low estimate of $428.00 to a high estimate of $585.00. This average target implies a growth of 23.82% compared to the current stock price of $408.31.
Consensus Price Target
$505.55
Highest Price Target
$585.00
Lowest Price Target
$428.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 13 | 13 | 13 |
| Hold | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ELV Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is QuantumScape a Buy Now?
QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…
Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
62
RGC alert for May 2
Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.
Sell
36
WGS alert for May 2
GeneDx Holdings [WGS] is down 6.85% over the past day.
Sell
42
VICR alert for May 2
Vicor [VICR] is down 1.28% over the past day.
